In a society where facts are distorted and falsehoods proliferate, individuals are robbed of the ability to make sound ...
At one dose, the vaccine was found to be 75.2% effective. Back in 2022, when initial supplies were constrained, the FDA issued an emergency use authorization (EUA) allowing intradermal ...
The Jynneos vaccine comes in two doses and is recommended for those who have been exposed to someone with mpox as well as ...
Vaccine protection against mpox fades quickly in the human immune system, even in people who've received the full two-dose regimen, a new real-world study shows. Antibody levels fell to low or ...
This was used as a dose-saving strategy as supplies were initially limited. The vaccine has been shown to be efficacious in studies using real-world data from the 2022 and onward outbreak among ...
Chemical biologists design an early 'proof-of-concept' vaccine that could lead to the first effective treatment of xylazine overdose in people. Xylazine is an FDA-approved sedative and pain ...
Labcorp (NYSE:LH) announced Wednesday that the U.S. Food and Drug Administration (FDA) granted emergency use authorization for its Mpox PCR Test Home Collection Kit, which can be used to detect ...
This is a study of a vaccine approved by the U.S. Food and Drug Administration (FDA) for adults to prevent monkeypox, now called mpox ... approved the use of two (0.5 mL) doses of JYNNEOS given ...
The 1.5 mg and 4.5 mg doses of Trulicity, another diabetes drug by Lilly, will also be available in limited amounts through April due to increased demand, according to the FDA's website.
The Food and Drug Administration ... (MenABCWY) vaccine candidate. The application is supported by data from a phase 3 trial (ClinicalTrials.gov Identifier: NCT04502693) in which study participants ...
With a final decision expected next February, MenABCWY combines the protective elements of GSK’s existing vaccines to target the five primary serogroups of Neisseria meningitidis. GSK announced that ...